retatrutide dose clinical trials Phase III study demonstrates 30% weight loss VisualAbstract: Retatrutide reduces body weight

Visit our Wight Loss Treatment Plan page to review candidacy pricing and request your consultation.

2 Factors such as a metabolic phenotype, presence of comorbidities, and individual sensitivity to hormonal fluctuations and weight loss play a critical role in treatment response

To that effect, some employers are recommending or even requiring participation in lifestyle modification programs , which have been shown to increase adherence and weight loss maintenance

Rapid weight loss, hormonal shifts, and medication changes can make this existing tendency more obvious

Conversely, patients with diabetes or metabolic dysfunction often see greater benefit from tirzepatide's dual-receptor activation, which improves glycemic control alongside weight reduction

Kolkhof et al